Five Ways Brisbane Diamantina Health Partners Is Tackling Antimicrobial Resistance

Antimicrobial resistance (AMR) is changing the way hospitals prevent, diagnose, and treat infection. When bacteria, viruses, fungi, or parasites no longer respond reliably to medicines, routine infections can become harder to manage, hospital stays may lengthen, and patients can face more complex treatment decisions.

Hospitals need coordinated action because resistance is shaped by prescribing, infection control, laboratory testing, patient movement, and the use of antibiotics across the wider community. Research must therefore move quickly into clinical practice, while frontline experience should help shape the questions researchers investigate.

As a Queensland health translation collaborative, Brisbane Diamantina Health Partners connects health services, universities, research institutes, clinicians, and communities. Its health research network provides a framework for turning evidence about antimicrobial stewardship and infection prevention into practical improvements for patients and healthcare teams.

Using Data To Detect Resistance Earlier

A strong response to AMR begins with reliable information. Hospitals can monitor which organisms are appearing, which antibiotics are effective against them, and where resistant infections are occurring. This surveillance helps clinicians recognise emerging patterns before they become widespread problems.

Shared analysis is especially valuable across hospitals and laboratories. It can reveal changes in resistance rates, identify high-risk wards, and support decisions about empirical treatment while test results are pending. Clear, timely reporting also helps infection prevention teams target their resources rather than relying on assumptions.

Research partnerships can strengthen this work by combining laboratory science, clinical records, epidemiology, and health service data. Translation specialists help convert technical findings into dashboards, protocols, and alerts that are understandable and useful during busy clinical workflows.

Improving Antimicrobial Stewardship

Antimicrobial stewardship means using the right medicine, dose, route, and duration for a confirmed or suspected infection. It also means avoiding antibiotics when they are unlikely to help, such as in many viral illnesses. This protects patients from unnecessary side effects and reduces selective pressure that encourages resistant organisms.

Hospital stewardship programs commonly bring together infectious disease physicians, pharmacists, microbiologists, nurses, and prescribing clinicians. They may review complex prescriptions, support antibiotic “time-outs,” and promote de-escalation when laboratory results identify a narrower treatment option.

The most effective approaches fit local practice. A collaborative network can compare evidence across services, evaluate whether an intervention changes prescribing, and refine guidance with input from the people using it. This creates a cycle in which clinical experience informs research and new evidence improves everyday care.

Strengthening Infection Prevention And Control

Preventing infection removes the need for treatment in the first place. Hand hygiene, environmental cleaning, appropriate use of personal protective equipment, safe device care, and careful isolation procedures all help reduce transmission within hospitals.

AMR control also depends on recognising how patients move between emergency departments, wards, operating theatres, aged-care facilities, outpatient clinics, and home. Communication during transfers can ensure that important information about colonisation, previous cultures, or recent antibiotic exposure is not lost.

Health services can test infection prevention measures through quality improvement projects and implementation research. This makes it possible to understand whether a policy works in a particular setting, what barriers staff encounter, and which changes produce sustained improvements rather than short-term compliance.

Connecting Diagnostics With Treatment Decisions

Rapid and accurate diagnosis can reduce unnecessary broad-spectrum antibiotic use. Microbiology cultures, molecular tests, susceptibility testing, and clinical assessment each provide different pieces of information. Used well, they help clinicians distinguish bacterial infection from other conditions and select more targeted therapy.

The value of a test depends on what happens after the result is available. Laboratories, pharmacists, and clinical teams need communication systems that deliver actionable findings quickly. An alert about a resistant organism, for example, may prompt a change in treatment, additional precautions, or review of close contacts.

Collaborative research can assess both the accuracy of diagnostic tools and their real-world impact. A test that performs well in a laboratory still needs to fit hospital workflows, staffing models, costs, and patient needs before it can improve antimicrobial use.

Building Skills Across The Health Workforce

AMR is a shared responsibility, so education must extend beyond a small specialist team. Doctors, nurses, pharmacists, laboratory professionals, allied health workers, students, and support staff all influence how infections are recognised, treated, and prevented.

Practical education can include case-based learning, prescribing feedback, simulation, ward-based coaching, and updates on local resistance trends. Training is more likely to change behaviour when it addresses real clinical decisions, such as when to collect cultures, how to review an antibiotic order, or how to explain treatment choices to a patient.

Universities and health services can jointly develop education that reflects Queensland’s clinical environments. Professional development also supports a pipeline of researchers and practitioners who understand both the science of AMR and the operational realities of hospital care.

Turning Partnerships Into Lasting Action

AMR cannot be solved by a single discipline or institution. Partnerships allow hospitals to share expertise, align priorities, pursue funding, and evaluate interventions across different patient populations. They can also connect hospital-based work with public health, primary care, aged care, and community organisations.

Governance and ethics are important when projects use patient information, compare services, or introduce new models of care. Clear responsibilities, secure data practices, and meaningful consumer involvement help ensure that research is trustworthy and focused on outcomes that matter to patients, families, carers, and communities.

Useful priorities for health services and research partners include:

• Establishing shared measures for antibiotic use, resistant infections, diagnostic turnaround, and patient outcomes.
• Giving frontline clinicians and consumers a role in designing stewardship and infection prevention projects.
• Combining local surveillance with national and international AMR guidance.
• Evaluating whether interventions remain effective after initial funding, training, or leadership changes.
• Sharing successful methods through education, publications, governance forums, and clinical networks.

This partnership model supports translation: evidence is tested in practice, results are measured, and successful approaches are adapted for wider use. It also helps hospitals respond to AMR as an ongoing patient-safety priority rather than a short-term campaign.

Brisbane Diamantina Health Partners brings together the connections needed to move antimicrobial resistance research into clinical improvement. Explore its research, partnerships, education, and health service activity to follow how collaborative action can support safer prescribing, stronger infection prevention, and better outcomes across Queensland.